Biomolecules | Free Full-Text | Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study
Characterisation of the glycosylation of Humira (adalimumab) and Erbitux (Cetuximab) by high resolution mass spectrometry | Quality Assistance
Peptide Mapping LC-MS/MS Analysis Workflow for Adalimumab
Frontiers | Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial
Figure 5 from Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases | Semantic Scholar
Structural Biology of the TNF Antagonists Used in the Treatment of Rheumatoid Arthritis
Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line | SpringerPlus | Full Text
The amino acid sequences of abatacept, alefacept, etanercept, and H... | Download Scientific Diagram
Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira) - Journal of Pharmaceutical Sciences
Primary structure of HLX03 and CN-Humira®. a Tryptic peptide maps; MS... | Download Scientific Diagram
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease - ScienceDirect
B. Space-filling models of the monoclonal antibody Adalimumab (Humira)... | Download Scientific Diagram
AbbVie 2017: Humira, And What's Next – PharmaLive
Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases
FDA Grants Interchangeable Status to Humira Biosimilar, but Certain Factors May Hamper Its, Other Adalimumabs' Uptake - MMIT Network
Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line | SpringerPlus | Full Text
Amino acid sequences of adalimumab variable heavy (VH) and light chain... | Download Scientific Diagram
Frontiers | Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis | NEJM
3 Adalimumab
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study
Biomolecules | Free Full-Text | Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study
Humira
Characterisation of the glycosylation of Humira (adalimumab) and Erbitux (Cetuximab) by high resolution mass spectrometry | Quality Assistance
One Hundred Days of Humira Biosimilars - IQVIA
Fab Fc Fv
AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES